Themis Medicare Limited
NSE: THEMISMED | Information Technology
Market Fundamentals
Stock Intelligence & News
Gujarat Themis Biosyn Limited
Sachin D. Patel has Submitted to the Exchange a copy of Disclosure under Regulation 10 (5) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |SUBJECT: Disclosure under SEBI Takeover Regulations
Read Full Analysis →Gujarat Themis Biosyn Limited
Sachin D. Patel has submitted to the Exchange a copy of Disclosures under Regulation 10(6)-Report to stock Exchange in respect of any acquisition made in reliance upon exemption provided for in regulation 10 of SEBI (SAST) Regulations, 2011. |SUBJECT: Disclosure under SEBI Takeover Regulations
Read Full Analysis →Gujarat Themis Biosyn Limited
Gujarat Themis Biosyn Limited has informed the Exchange about Investor Presentation |SUBJECT: Investor Presentation
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Gujarat Themis Biosyn Limited
Gujarat Themis Biosyn Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company |SUBJECT: Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
Read Full Analysis →Gujarat Themis Biosyn Limited
Sachin D. Patel has Submitted to the Exchange a copy of Disclosure under Regulation 10 (5) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |SUBJECT: Disclosure under SEBI Takeover Regulations
Read Full Analysis →Themis Medicare Limited
Significant increase in volume has been observed in Themis Medicare Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Themis Medicare Limited has submitted their response. |SUBJECT: Spurt in Volume
Read Full Analysis →Gujarat Themis Biosyn Limited
Board Meeting Intimation |Meeting Date: 19-Jun-2026
Read Full Analysis →Gujarat Themis Biosyn Limited
The Exchange has sought clarification from Gujarat Themis Biosyn Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: The response of the Company is awaited. |SUBJECT: Clarification - Financial Results
Read Full Analysis →Gujarat Themis Biosyn Limited
Gujarat Themis Biosyn Limited has informed the Exchange about General Updates |SUBJECT: General Updates
Read Full Analysis →Gujarat Themis Biosyn Limited
Gujarat Themis Biosyn Limited has informed the Exchange about Copy of Newspaper Publication |SUBJECT: Copy of Newspaper Publication
Read Full Analysis →Get instant alerts when THEMISMED breaks news
Join investors who track Themis Medicare Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for THEMISMED?
THEMISMED is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Themis Medicare Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding THEMISMED to your custom watchlist.